| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $776K | — | +46.9% |
| SG&A Expense | $1.4M | — | +59.8% |
| Operating Income | -$2.2M | — | -47.9% |
| Pre-tax Income | -$1.3M | — | -26.5% |
| Net Income | -$1.3M | — | -26.5% |
| EPS (Basic) | -$1.09 | — | +41.4% |
| EPS (Diluted) | -$1.09 | — | +41.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $537K | -44.6% | -75.4% |
| Total Assets | $3.4M | -10.8% | +8.4% |
| Current Liabilities | $835K | +11.3% | +47.7% |
| Total Liabilities | $1.7M | +3.6% | +16.5% |
| Stockholders' Equity | $1.8M | -20.9% | +1.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.1M | — | +13.4% |
| Capital Expenditures | $17K | — | +0.0% |
| Investing Cash Flow | $450K | — | +2704.2% |
| Financing Cash Flow | $264K | — | +80.9% |
| Free Cash Flow | -$1.1M | — | +13.2% |